Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Orphan Europe and CMIC sign Japanese license agreement for Normosang for hepatic porphyria

Dec. 22, 2008

First-in-human studies of HQK-1001 reported

Dec. 22, 2008

Eldecalcitol reduces incidence of new vertebral fractures in phase III trial

Dec. 19, 2008

Merck & Co. initiates phase I clinical development of estrogen receptor compound

Dec. 19, 2008

New contraceptive agents reported in recent Organon patent

Dec. 17, 2008

Novel Syk inhibitor prevents heparin-induced thrombocytopenia in vivo

Dec. 17, 2008

EXTEND, RAISE studies add to data on recently approved eltrombopag

Dec. 17, 2008

FDA approves Abbott's Trilipix for patients with mixed dyslipidemia

Dec. 17, 2008

Genfit commences phase II GFT-505 trial in patients with prediabetes

Dec. 17, 2008

Vivus initiates phase III avanafil trial in erectile dysfunction

Dec. 17, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...